Literature DB >> 8189748

[3H]WIN 35,428 binding to the dopamine uptake carrier. II. Effect of membrane fractionation procedure and freezing.

M E Reith1, L L Coffey.   

Abstract

In the present study the dopamine transporter on rat striatal membranes was labeled with [3H]WIN 35,428 (2 beta-carbomethoxy-3 beta-(4-fluorophenyl)-tropane) and its binding state or form was compared between fresh and frozen tissue fractionated by various protocols. Freezing striatal tissue resulted in a decrease in binding to crude or P2 membranes, but did not consistently generate upward concave Scatchard plots. Among various conditions, sodium phosphate buffers containing sucrose, employed for homogenization and for measurement of binding to freshly prepared P2 membranes, were most likely to give multiple binding component resolutions. These results allow us to reconcile the existing literature on [3H]WIN 35,428 binding and to identify (1) the 'universal' binding component common to all studies thus far, (2) a high-affinity component measured with sufficiently low ligand concentration, and (3) a low-affinity component observed with sufficiently high ligand concentration.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8189748     DOI: 10.1016/0165-0270(94)90023-x

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  7 in total

1.  Dopamine transporter oligomerization: impact of combining protomers with differential cocaine analog binding affinities.

Authors:  Juan Zhen; Tamara Antonio; Shu-Yuan Cheng; Solav Ali; Kymry T Jones; Maarten E A Reith
Journal:  J Neurochem       Date:  2015-01-26       Impact factor: 5.372

2.  Recombinant human immunodeficiency virus-1 transactivator of transcription1-86 allosterically modulates dopamine transporter activity.

Authors:  Jun Zhu; Subramaniam Ananthan; Charles F Mactutus; Rosemarie M Booze
Journal:  Synapse       Date:  2011-05-17       Impact factor: 2.562

3.  Protein kinase Cbeta is a critical regulator of dopamine transporter trafficking and regulates the behavioral response to amphetamine in mice.

Authors:  Rong Chen; Cheryse A Furman; Minjia Zhang; Myung N Kim; Robert W Gereau; Michael Leitges; Margaret E Gnegy
Journal:  J Pharmacol Exp Ther       Date:  2008-12-19       Impact factor: 4.030

4.  HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes.

Authors:  Jun Zhu; Charles F Mactutus; David R Wallace; Rosemarie M Booze
Journal:  J Pharmacol Exp Ther       Date:  2009-03-26       Impact factor: 4.030

5.  HIV-1 transgenic rats display an increase in [(3)H]dopamine uptake in the prefrontal cortex and striatum.

Authors:  Jun Zhu; Yaxia Yuan; Narasimha M Midde; Adrian M Gomez; Wei-Lun Sun; Pamela M Quizon; Chang-Guo Zhan
Journal:  J Neurovirol       Date:  2015-10-26       Impact factor: 2.643

6.  Mutational effects of human dopamine transporter at tyrosine88, lysine92, and histidine547 on basal and HIV-1 Tat-inhibited dopamine transport.

Authors:  Wei-Lun Sun; Pamela M Quizon; Yaxia Yuan; Matthew J Strauss; Richard McCain; Chang-Guo Zhan; Jun Zhu
Journal:  Sci Rep       Date:  2019-03-07       Impact factor: 4.379

7.  Mutations of Human DopamineTransporter at Tyrosine88, Aspartic Acid206, and Histidine547 Influence Basal and HIV-1 Tat-inhibited Dopamine Transport.

Authors:  Pamela M Quizon; Yaxia Yuan; Yike Zhu; Yi Zhou; Matthew J Strauss; Wei-Lun Sun; Chang-Guo Zhan; Jun Zhu
Journal:  J Neuroimmune Pharmacol       Date:  2021-02-03       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.